Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Language
Publication year range
1.
Braz J Cardiovasc Surg ; 35(6): 1010-1012, 2020 12 01.
Article in English | MEDLINE | ID: mdl-33306328

ABSTRACT

We report the case of a 60-year-old patient who underwent orthotopic heart transplant 14 years earlier. Routine echocardiography showed giant masses in the left atrium. There were no symptoms or thromboembolic events in the past. Magnetic resonance imaging study revealed very enlarged left atrium (8.7 × 10.6 cm) occupied by irregular smooth mass (7 × 5 × 6.1 cm) with a stalk that was attached to the posterior left atrial wall in the area of graft suture lines. Intraoperative examination revealed a massive thrombus (12 × 10 cm) that filled almost the entire left atrial area.


Subject(s)
Heart Diseases , Heart Transplantation , Thromboembolism , Thrombosis , Echocardiography , Heart Atria/diagnostic imaging , Heart Diseases/diagnostic imaging , Heart Diseases/etiology , Heart Diseases/surgery , Heart Transplantation/adverse effects , Humans , Middle Aged , Thrombosis/diagnostic imaging , Thrombosis/etiology
2.
Rev. bras. cir. cardiovasc ; Rev. bras. cir. cardiovasc;35(6): 1010-1012, Nov.-Dec. 2020. tab, graf
Article in English | LILACS, Sec. Est. Saúde SP | ID: biblio-1143999

ABSTRACT

Abstract We report the case of a 60-year-old patient who underwent orthotopic heart transplant 14 years earlier. Routine echocardiography showed giant masses in the left atrium. There were no symptoms or thromboembolic events in the past. Magnetic resonance imaging study revealed very enlarged left atrium (8.7 × 10.6 cm) occupied by irregular smooth mass (7 × 5 × 6.1 cm) with a stalk that was attached to the posterior left atrial wall in the area of graft suture lines. Intraoperative examination revealed a massive thrombus (12 × 10 cm) that filled almost the entire left atrial area.


Subject(s)
Humans , Middle Aged , Thromboembolism , Thrombosis/diagnostic imaging , Heart Transplantation/adverse effects , Heart Diseases/surgery , Heart Diseases/etiology , Heart Diseases/diagnostic imaging , Thrombosis/etiology , Echocardiography , Heart Atria/diagnostic imaging
3.
Rev. bras. cir. cardiovasc ; Rev. bras. cir. cardiovasc;33(6): 553-558, Nov.-Dec. 2018. tab, graf
Article in English | LILACS | ID: biblio-977479

ABSTRACT

Abstract Objective: The aim of this study was to compare the efficacy of two different papaverine concentrations (0.5 mg/ml and 2 mg/ml) for vasospasm prevention and their impact on endothelium integrity. Methods: We have studied distal segments of radial arteries obtained by no-touch technique from coronary artery bypass graft (CABG) patients (n=10). The vasodilatory effect of papaverine (concentrations of 0.5 mg/ml and 2 mg/ml) was assessed in vitro, in isometric tension studies using ex vivo myography (organ bath technique) and arterial rings precontracted with potassium chloride (KCl) and phenylephrine. The impact of papaverine on endothelial integrity was studied by measurement of the percentage of vessel's circumference revealing CD34 endothelial marker. Results: 2 mg/ml papaverine concentration showed stronger vasodilatatory effect than 0.5 mg/ml, but it caused significantly higher endothelial damage. Response to KCl was 7.35±3.33 mN for vessels protected with papaverine 0.5 mg/ml and 2.66±1.96 mN when papaverine in concentration of 2 mg/ml was used. The histological examination revealed a significant difference in the presence of undamaged endothelium between vessels incubated in papaverine 0.5 mg/ml (72.86±9.3%) and 2 mg/ml (50.23±13.42%), P=0.002. Conclusion: Papaverine 2 mg/ml caused the higher endothelial damage. Concentration of 0.5 mg/ml caused better preservation of the endothelial lining.


Subject(s)
Humans , Male , Female , Aged , Papaverine/administration & dosage , Vasodilator Agents/administration & dosage , Coronary Artery Disease/surgery , Endothelium, Vascular/drug effects , Radial Artery/drug effects , Coronary Vasospasm/prevention & control , Papaverine/adverse effects , Papaverine/pharmacology , Vasoconstriction/drug effects , Vasodilation/drug effects , Vasodilator Agents/adverse effects , Vasodilator Agents/pharmacology , Coronary Artery Disease/physiopathology , Coronary Artery Bypass/methods
4.
Braz J Cardiovasc Surg ; 33(6): 553-558, 2018.
Article in English | MEDLINE | ID: mdl-30652743

ABSTRACT

OBJECTIVE: The aim of this study was to compare the efficacy of two different papaverine concentrations (0.5 mg/ml and 2 mg/ml) for vasospasm prevention and their impact on endothelium integrity. METHODS: We have studied distal segments of radial arteries obtained by no-touch technique from coronary artery bypass graft (CABG) patients (n=10). The vasodilatory effect of papaverine (concentrations of 0.5 mg/ml and 2 mg/ml) was assessed in vitro, in isometric tension studies using ex vivo myography (organ bath technique) and arterial rings precontracted with potassium chloride (KCl) and phenylephrine. The impact of papaverine on endothelial integrity was studied by measurement of the percentage of vessel's circumference revealing CD34 endothelial marker. RESULTS: 2 mg/ml papaverine concentration showed stronger vasodilatatory effect than 0.5 mg/ml, but it caused significantly higher endothelial damage. Response to KCl was 7.35±3.33 mN for vessels protected with papaverine 0.5 mg/ml and 2.66±1.96 mN when papaverine in concentration of 2 mg/ml was used. The histological examination revealed a significant difference in the presence of undamaged endothelium between vessels incubated in papaverine 0.5 mg/ml (72.86±9.3%) and 2 mg/ml (50.23±13.42%), P=0.002. CONCLUSION: Papaverine 2 mg/ml caused the higher endothelial damage. Concentration of 0.5 mg/ml caused better preservation of the endothelial lining.


Subject(s)
Coronary Artery Disease/surgery , Coronary Vasospasm/prevention & control , Endothelium, Vascular/drug effects , Papaverine/administration & dosage , Radial Artery/drug effects , Vasodilator Agents/administration & dosage , Aged , Coronary Artery Bypass/methods , Coronary Artery Disease/physiopathology , Female , Humans , Male , Papaverine/adverse effects , Papaverine/pharmacology , Vasoconstriction/drug effects , Vasodilation/drug effects , Vasodilator Agents/adverse effects , Vasodilator Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL